10.1371/journal.pone.0100365 328
The FDA warned against the use of compounded semaglutide more broadly, noting that these reformulated therapies pose a higher risk to patients than approved medicines because they do not undergo FDA premarket review for safety, effectiveness or quality. Patients should only be on compounded medication if their medical needs cannot be met by an available FDA-approved drug. Weight-loss therapies have been growing rapidly in recent months, with Novo Nordisks Wegovy (semaglutide) and Eli Lillys Zepbound (tirzepatide) currently dominating the space and other competitors looking target the lucrative market
Anti-TNFs' known safety profile has been confirmed, proving safe during the COVID-19 pandemic and expanded their use within pregnancy and lactation
While trying to compensate for the dryness from AC, sebaceous glands often overcorrect once you are back in humid air, which is why so many people describe their skin as oily and dehydrated at the same time
Tang NP, Zhou B, Wang B, Yu RB, Ma J
Nausea and digestive issues are among the most reported, underscoring the need for careful dose titration and ongoing clinical supervision